| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/29/2009 | CN101420955A Dihydrodiazepines useful as inhibitors of protein kinases |
| 04/29/2009 | CN101420948A Intramuscular antiviral treatments |
| 04/29/2009 | CN101418334A Diterpenes diterpenoids natural product inhibitor for main protease of coronaviruses such as SARS and screen method thereof |
| 04/29/2009 | CN101418303A Method for preparing swine fever recombinant subunit vaccine |
| 04/29/2009 | CN101418294A Antisense nucleic acid of methicillin-resistant staphylococcus aureus resistance gene mecA |
| 04/29/2009 | CN101418275A Streptococcus suis type 2 immune protective antigen |
| 04/29/2009 | CN101418039A Novel antibacterial peptide and preparation method and use thereof |
| 04/29/2009 | CN101418036A Rapid purification of gamma trichosanthin and crystallization technology thereof |
| 04/29/2009 | CN101418017A Method for synthesizing (R)-9-(2-phosphate methoxy propyl)adenine |
| 04/29/2009 | CN101418016A Phosphorylation cephalosporin derivates |
| 04/29/2009 | CN101418015A Ceftriaxone phosphorylation derivates |
| 04/29/2009 | CN101418005A Novel method for synthesizing prulifloxacin |
| 04/29/2009 | CN101417133A Slow-release medicine intercalation magnetic hydrotalcite with fluorescence radiation performance and preparation method thereof |
| 04/29/2009 | CN101417128A Preparation of BCG vaccine polysaccharide nucleic acid -DDA adjuvant and use thereof |
| 04/29/2009 | CN101417122A Recombination chicken alpha-interferon injection and preparation method thereof |
| 04/29/2009 | CN101417116A Decoction for treating urgent hepatitis with jaundice |
| 04/29/2009 | CN101417115A Traditional Chinese medicine for acute infectious hepatitis with jaundice |
| 04/29/2009 | CN101417105A Zedoary turmeric oil glucose injection and preparation method thereof |
| 04/29/2009 | CN101417100A Medicine for treating secondary lung tuberculosis and preparation method thereof |
| 04/29/2009 | CN101417098A External medicine for treating male and female venereal disease |
| 04/29/2009 | CN101417075A Traditional Chinese medicine for treating respiratory system disease |
| 04/29/2009 | CN101417068A Traditional Chinese medicine bacteriostatic lotion and preparation method thereof |
| 04/29/2009 | CN101417052A Plaster for treating parotitis and use method thereof |
| 04/29/2009 | CN101417050A Traditional Chinese medicine preparation for treating acute jaundice |
| 04/29/2009 | CN101417049A Anti-AIDS traditional Chinese medicine compound composite and preparation method thereof |
| 04/29/2009 | CN101417032A Traditional Chinese medicine composition for treating infectious larngotracheitis |
| 04/29/2009 | CN101417018A Preparation method of animal injection capable of clearing away the heat-evil and expelling superficial evils, cooling blood and relieving dysentery |
| 04/29/2009 | CN101417016A Traditional Chinese medicine composition for treating Escherichia coli |
| 04/29/2009 | CN101417014A Traditional Chinese medicine composition for treating stramgutia and preparation method and quality control method thereof |
| 04/29/2009 | CN101417009A Avian influenza resistance traditional Chinese medicine composition |
| 04/29/2009 | CN101417008A Biberberine for injection as veterinary herb medicine composite preparation and preparation technique and use thereof |
| 04/29/2009 | CN101416987A Honey acid, preparation and application thereof |
| 04/29/2009 | CN101416978A Preparation method of tilmicosin long-acting injection |
| 04/29/2009 | CN101416977A Preparation method of azalide type tulathromvcin injection |
| 04/29/2009 | CN101416974A Preparation method of doxycycline long-acting injection |
| 04/29/2009 | CN101416973A Preparation method of novel composite anti-coccidium, antibiotic preparation |
| 04/29/2009 | CN101416972A External medicine capable of preventing and treating cardiovascular disease and preparation method thereof |
| 04/29/2009 | CN101416968A Preparation method of ceftiofur long-acting injector |
| 04/29/2009 | CN101416964A Use of sophocarpine in preparing medicine for treating diseases induced by coxsackie B virus |
| 04/29/2009 | CN101416958A Use of 15-methano-substituted-andrographolide derivative in preparing anti-hepatitis B medicine |
| 04/29/2009 | CN101416957A Use of resveratrol or naringenin in preventing and treating diabetic nephropathy |
| 04/29/2009 | CN101416951A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416950A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416945A Preparation method of azithromycin fine granule |
| 04/29/2009 | CN101416937A Preparation method of new cephalosporin compound formulation |
| 04/29/2009 | CN101416936A Preparation method of long-acting composite sulfamonomethoxine suspension |
| 04/29/2009 | CN101416935A Preparation method of composite sulfamethoxydiazine suspension |
| 04/29/2009 | CN100482788C High-yield recombinant influenza B virus strain and its application |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/29/2009 | CN100482683C Active fragment of human glycine-rich protein and use thereof |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482660C Flouroquinolone-oxazolidone derivative, composition, preparation method and application thereof |
| 04/29/2009 | CN100482280C Highly compressible ethylcellulose for tableting |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482274C B-type hepatitis and E-type hepatitis combined vaccine and preapring method |
| 04/29/2009 | CN100482273C Capsular polysaccharide solubilisation and combination vaccines |
| 04/29/2009 | CN100482252C Medicinal composition for treating hepatitis B |
| 04/29/2009 | CN100482245C Medicine composition contg. isatis root and scutellariae glucoside |
| 04/29/2009 | CN100482236C Beta-L-2'-dioxidition-nucleoside for treating hepatitis B |
| 04/29/2009 | CN100482231C Cefepime hydrochloride powder injection and preparing method thereof |
| 04/29/2009 | CN100482225C Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/29/2009 | CN100482219C Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482213C Monascus pellet and its preparing method |
| 04/28/2009 | US7524956 Hemisynthetic method and new compounds |
| 04/28/2009 | US7524932 Lactalbumin production process |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524854 Trimethoprim derivative; 5-[6,7-Dimethoxy-2-(7-methoxy-1H-indol-3-ylmethyl)-benzofuran-4-ylmethyl]-pyrimidine-2,4-diamine; potent activity against dihydrofolate reductase, mutated enzyme; superior bioavailability, antibacterial activity; gram positive and negative pathogens |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524841 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524828 Immunostimulatory nucleic acid molecules |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524517 Methods and compositions for P2X receptor calcium entry channels and other calcium entry mechanisms |
| 04/28/2009 | US7524506 gM-negative EHV-mutants without heterologous elements |
| 04/28/2009 | US7524503 Antigens; vaccines; isolated peptide |
| 04/28/2009 | US7524488 Interleukin-18 mutants |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |
| 04/28/2009 | CA2496864C A pharmaceutical composition |
| 04/28/2009 | CA2465336C Novel carbapenem compounds |
| 04/28/2009 | CA2450949C Methods and compositions for polyene antibiotics with reduced toxicity |
| 04/28/2009 | CA2430734C Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 04/28/2009 | CA2429793C Interferon therapeutic effect enhancer |
| 04/28/2009 | CA2425314C Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2334761C Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use |
| 04/28/2009 | CA2278479C Carbohydrate mixture |
| 04/28/2009 | CA2222964C Oxygen activatable formulations for disinfection or sterilization |
| 04/28/2009 | CA2212382C Cochleate delivery vehicles |
| 04/23/2009 | WO2009052090A2 Silicate containing compositions and methods of treatment |
| 04/23/2009 | WO2009052050A1 Dioxolane thymine phosphoramidates as anti-hiv agents |
| 04/23/2009 | WO2009051796A2 2,5-diaryl selenophene compounds, aza 2,5-diaryl thiophene compounds, and their prodrugs as antiprotozoal agents |
| 04/23/2009 | WO2009051782A1 Deuterated etravirine |
| 04/23/2009 | WO2009051648A2 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |